At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Cytostatic antibiotics
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 24 May 2001 Discontinued-Preclinical for Cancer in Australia (Unknown route)
- 09 Jul 1998 Profile reviewed
- 09 Jul 1998 No-Development-Reported for Cancer in Australia (Unknown route)